Marwan Sabbagh on Donanemab Confirms: Clearing Plaques Slows Decline—By a Bit
COMMENT I am impressed with the donanemab data for several reasons. The design is informed based on previous studies. The titration up is appropriate. The selection of intermediate tau load is novel. The pyro-glu epitope is downstream from oligomeric species, ...